These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 33991177)
21. Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing. Liu Y; Ferguson FM; Li L; Kuljanin M; Mills CE; Subramanian K; Harshbarger W; Gondi S; Wang J; Sorger PK; Mancias JD; Gray NS; Westover KD Cell Chem Biol; 2020 Oct; 27(10):1229-1240.e4. PubMed ID: 32755567 [TBL] [Abstract][Full Text] [Related]
22. Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer. Tao H; Tanaka T; Okabe K J Cancer Res Clin Oncol; 2017 Aug; 143(8):1449-1459. PubMed ID: 28382517 [TBL] [Abstract][Full Text] [Related]
23. DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis. Kim JH; Park SY; Jeon SE; Choi JH; Lee CJ; Jang TY; Yun HJ; Lee Y; Kim P; Cho SH; Lee JS; Nam JS Theranostics; 2022; 12(12):5258-5271. PubMed ID: 35910805 [No Abstract] [Full Text] [Related]
24. Targeting colon cancer stem cells using novel doublecortin like kinase 1 antibody functionalized folic acid conjugated hesperetin encapsulated chitosan nanoparticles. Lazer LM; Kesavan Y; Gor R; Ramachandran I; Pathak S; Narayan S; Anbalagan M; Ramalingam S Colloids Surf B Biointerfaces; 2022 Sep; 217():112612. PubMed ID: 35738074 [TBL] [Abstract][Full Text] [Related]
25. Induction of let-7e gene expression attenuates oncogenic phenotype in HCT-116 colorectal cancer cells through targeting of DCLK1 regulation. Khodadadi Kohlan A; Saidijam M; Amini R; Samadi P; Najafi R Life Sci; 2019 Jul; 228():221-227. PubMed ID: 31075231 [TBL] [Abstract][Full Text] [Related]
26. DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition. Chandrakesan P; Weygant N; May R; Qu D; Chinthalapally HR; Sureban SM; Ali N; Lightfoot SA; Umar S; Houchen CW Oncotarget; 2014 Oct; 5(19):9269-80. PubMed ID: 25211188 [TBL] [Abstract][Full Text] [Related]
27. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases. Ali N; Chandrakesan P; Nguyen CB; Husain S; Gillaspy AF; Huycke M; Berry WL; May R; Qu D; Weygant N; Sureban SM; Bronze MS; Dhanasekaran DN; Houchen CW Oncotarget; 2015 Aug; 6(24):20327-44. PubMed ID: 25948779 [TBL] [Abstract][Full Text] [Related]
28. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis. Kang XL; He LR; Chen YL; Wang SB World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966 [TBL] [Abstract][Full Text] [Related]
29. Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanism. Ali N; Nguyen CB; Chandrakesan P; Wolf RF; Qu D; May R; Goretsky T; Fazili J; Barrett TA; Li M; Huycke MM; Bronze MS; Houchen CW Sci Rep; 2020 Jun; 10(1):10578. PubMed ID: 32601309 [TBL] [Abstract][Full Text] [Related]
30. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma. Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702 [TBL] [Abstract][Full Text] [Related]
31. The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer. Gzil A; Szylberg Ł; Jaworski D; Dominiak J; Zarębska I; Grzanka D Anticancer Res; 2019 Jun; 39(6):2689-2697. PubMed ID: 31177103 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1. Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010 [TBL] [Abstract][Full Text] [Related]
33. DCLK1-Short Splice Variant Promotes Esophageal Squamous Cell Carcinoma Progression via the MAPK/ERK/MMP2 Pathway. Ge Y; Fan X; Huang X; Weygant N; Xiao Z; Yan R; Liu H; Liu J; An G; Yao J Mol Cancer Res; 2021 Dec; 19(12):1980-1991. PubMed ID: 34610960 [TBL] [Abstract][Full Text] [Related]
34. Epigenetic Landscape and Therapeutic Implication of Gene Isoforms of Doublecortin-Like Kinase 1 for Cancer Stem Cells. Moore LL; Houchen CW Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003596 [TBL] [Abstract][Full Text] [Related]
35. Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase. Weygant N; Ge Y; Qu D; Kaddis JS; Berry WL; May R; Chandrakesan P; Bannerman-Menson E; Vega KJ; Tomasek JJ; Bronze MS; An G; Houchen CW Cancer Res; 2016 Jul; 76(14):4090-9. PubMed ID: 27287716 [TBL] [Abstract][Full Text] [Related]
36. Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis. Ito H; Tanaka S; Akiyama Y; Shimada S; Adikrisna R; Matsumura S; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Yamaoka S; Tanabe M PLoS One; 2016; 11(1):e0146564. PubMed ID: 26764906 [TBL] [Abstract][Full Text] [Related]
37. DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner. Razi S; Sadeghi A; Asadi-Lari Z; Tam KJ; Kalantari E; Madjd Z Clin Exp Med; 2021 Feb; 21(1):139-147. PubMed ID: 32965580 [TBL] [Abstract][Full Text] [Related]
38. Role of DCLK1 in oncogenic signaling (Review). Lu Q; Feng H; Chen H; Weygant N; Du J; Yan Z; Cao Z Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36148883 [TBL] [Abstract][Full Text] [Related]
39. DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer. Sureban SM; May R; Qu D; Weygant N; Chandrakesan P; Ali N; Lightfoot SA; Pantazis P; Rao CV; Postier RG; Houchen CW PLoS One; 2013; 8(9):e73940. PubMed ID: 24040120 [TBL] [Abstract][Full Text] [Related]
40. Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas. Shafiei S; Kalantari E; Saeednejad Zanjani L; Abolhasani M; Asadi Lari MH; Madjd Z Exp Mol Pathol; 2019 Jun; 108():164-172. PubMed ID: 31028726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]